Case Summary (G.R. No. 166924)
Background of the Case
The case arose from complaints filed by Glaxo, along with Pfizer Phil., Inc. and Roche Phil., Inc., alleging that the respondents were engaged in the illegal sale and distribution of unregistered pharmaceutical drugs from their establishments in Parañaque City. Following these complaints, an entrapment operation was conducted by agents from the National Bureau of Investigation (NBI) against the respondents. During the operation, one of the respondents, Malik, was arrested for receiving payment for parallel imported drugs, while Ateeque evaded arrest.
Proceedings and Initial Findings
Following the arrest, an inquest investigation led to the filing of criminal cases against Malik and a preliminary investigation for Ateeque. However, on January 14, 2003, the Senior State Prosecutor dismissed the charges against both respondents, stating that the evidence provided by the complainants did not support an indictment. The dismissal was based on the conclusions that the respondents were engaged in parallel importation, which the government encourages to reduce drug prices, and that no law prohibited their actions.
Legal Review and Subsequent Appeals
Glaxo, dissatisfied with the dismissal, sought reconsideration, which was denied. The company escalated the matter to the Secretary of Justice, whose similar dismissals on June 17 and June 25, 2003, confirmed the Prosecutor's decision. Consequently, Glaxo filed a petition for certiorari with the Court of Appeals. The appeals court upheld that there was no grave abuse of discretion by the Secretary of Justice in denying Glaxo's petitions.
Supreme Court's Ruling
In the Supreme Court, the main issue was whether the courts could review a prosecutor's findings concerning probable cause. The Court reiterated the long-standing legal principle that courts generally do not interfere with the discretion exercised by prosecutors during preliminary investigations, except in cases of grave abuse of discretion. The Court found no such abuse in this case and concluded that th
...continue readingCase Syllabus (G.R. No. 166924)
Case Background
- This case involves a petition for review under Rule 45 of the Rules of Court filed by GlaxoSmithKline Philippines, Inc. (referred to as Glaxo) against respondents Khalid Mehmood Malik and Muhammad Ateeque.
- The case originated from the Decision dated October 28, 2004, of the Court of Appeals (CA) in CA-G.R. SP No. 78646, which affirmed the resolution of the Secretary of Justice dismissing Glaxo's petition for review regarding criminal cases against the respondents for alleged violations of Republic Acts No. 3720 and No. 8230.
Facts of the Case
- Glaxo, along with Pfizer Phil., Inc. and Roche Phil., Inc., filed letter-complaints alleging that the respondents were engaged in the illegal sale and distribution of unregistered imported pharmaceutical drugs in ParaAaque City.
- The National Bureau of Investigation (NBI) conducted operations wherein respondent Muhammad Ateeque displayed samples of drugs lacking registration from the Bureau of Food and Drugs (BFAD).
- On June 9, 2002, an entrapment operation led to the arrest of respondent Malik, who was caught receiving marked money for the sale of parallel imported drugs.
- Following the operation, Malik was found to have fluorescent powder on him, indicating his involvement in the illegal transaction.
Legal Proceedings
- An inquest